IMX PHARMACEUTICALS INC
10QSB, EX-27, 2000-08-21
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Previous: IMX PHARMACEUTICALS INC, 10QSB, 2000-08-21
Next: INNOTRAC CORP, 10-Q/A, 2000-08-21



<TABLE> <S> <C>


<ARTICLE>                     5





<S>                                                  <C>                           <C>
<PERIOD-TYPE>                                        3-MOS                          6-MOS
<FISCAL-YEAR-END>                                           DEC-31-2000                     DEC-31-2000
<PERIOD-START>                                              JAN-01-2000                     JAN-01-2000
<PERIOD-END>                                                MAR-31-2000                     JUN-30-2000
<CASH>                                                        1,219,267                         122,500
<SECURITIES>                                                     28,269                          28,269
<RECEIVABLES>                                                    96,430                          63,641
<ALLOWANCES>                                                      1,600                           1,600
<INVENTORY>                                                     710,628                       1,364,008
<CURRENT-ASSETS>                                              2,829,998                       3,834,334
<PP&E>                                                          104,085                         159,971
<DEPRECIATION>                                                   18,094                          31,883
<TOTAL-ASSETS>                                                3,011,729                       4,071,951
<CURRENT-LIABILITIES>                                           443,128                       1,274,432
<BONDS>                                                               0                               0
                                                 0                               0
                                                           0                               0
<COMMON>                                                          9,635                           9,735
<OTHER-SE>                                                    2,564,504                       2,289,119
<TOTAL-LIABILITY-AND-EQUITY>                                  3,011,729                       4,071,951
<SALES>                                                         231,346                       1,701,776
<TOTAL-REVENUES>                                                231,346                       1,701,776
<CGS>                                                            81,501                         439,471
<TOTAL-COSTS>                                                   832,565                       1,607,730
<OTHER-EXPENSES>                                              (245,493)                          15,884
<LOSS-PROVISION>                                                      0                               0
<INTEREST-EXPENSE>                                                (166)                           (166)
<INCOME-PRETAX>                                               (437,227)                       (361,309)
<INCOME-TAX>                                                          0                               0
<INCOME-CONTINUING>                                                   0                               0
<DISCONTINUED>                                                        0                               0
<EXTRAORDINARY>                                                       0                               0
<CHANGES>                                                             0                               0
<NET-INCOME>                                                  (437,227)                       (361,309)
<EPS-BASIC>                                                      (0.09)                          (0.06)
<EPS-DILUTED>                                                    (0.08)                          (0.06)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission